Status:
UNKNOWN
Vitamin D Estimation With Giardia Lamblia Infections
Lead Sponsor:
Sohag University
Conditions:
Giardia Lamblia Infection
Eligibility:
All Genders
Brief Summary
investigators will take stool and blood samples from two groups of humans :- 1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators m...
Detailed Description
In this research a case- control study will be used) ,the percentage of case to control will be 1:1 the total number of samples 192 ,investigators will take stool and blood samples from two groups of ...
Eligibility Criteria
Inclusion
- patient infected with Giardia lamblia.
Exclusion
- patient takes vitamin D supplement - patient has kidney disease- patient has liver disease-patient has a debilitating disease disease such as cancer or diabetes.
Key Trial Info
Start Date :
February 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT04778280
Start Date
February 17 2021
End Date
February 1 2022
Last Update
March 3 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Sohag University
Sohag, Egypt
2
Faculty of Medicine
Sohag, Egypt